期刊文献+

卵巢癌相关抗原CA125串联重复序列的原核表达纯化及抗血清制备 被引量:1

Prokaryotic expression and purification of a tandem repeat of ovarian cancer antigen CA125 and preparation of its antiserum
下载PDF
导出
摘要 目的:建立CA125串联重复序列(CA125R)原核表达系统,表达纯化重组CA125R蛋白并制备其抗血清。方法:全基因合成一段CA125串联重复序列,并将其克隆至pET-32a(+),构建CA125R蛋白原核表达载体pET-CA125R;将构建好的pET-CA125R载体转化至E.coli BL21(DE3),确定最佳可溶性表达条件,通过Ni-NTA亲和层析系统纯化重组CA125R蛋白;纯化重组蛋白经Western blot方法验证后,免疫家兔制备抗血清。结果:成功构建CA125串联重复序列原核表达载体,确定了最佳可溶性诱导表达条件(0.5 mmol/LIPTG,15℃诱导6 h);Western blot结果证实纯化的重组蛋白正确,纯度高;制备的抗血清能特异识别重组CA125R蛋白和天然CA125糖蛋白。结论:成功建立了CA125R高效原核表达系统,并制备了高纯度重组CA125R蛋白及其抗血清。 AIM: To establish a prokaryotic expression system of the tandem repeat of CA125 (CA125R), express and purify the recombinant CA125R protein, prepare its antiserum. METHODS: The full gene sequence of one tandem repeat of CA125 was synthesized and cloned into pET-32a( + ) to construct a prokaryoUc expression vector of the CA125R protein (pET-CA125R). The pET-CA125R was transformed into E. coli BL21 (DE3) and the soluble expres- sion conditions were optimized; the pure recombinant CA125R protein was prepared by affinity Ni-NTA chromatog- raphy and identified by Western blotting. A rabbit was immunized with the pure recombinant CA125R protein to prepare its antiserum. RESULTS: The prokaryotic expres- sion vector of CA125R was successfully constructed. The optimal soluble induction expression conditions were 0.5 mmol/L isopropyl β-D-1-thiogalactopyranoside (IPTG) at 15℃ for 6 h. Western blotting confirmed the pure CAI25R recombi- nant protein of high purity. The prepared antiserum specific- ally recognized recombinant CA125R protein and natural CA125 glycoprotein. CONCLUSION: We successfully es- tablished the efficient prokaryotic expression system of the CA125R, and prepared the recombinant CA125R protein of high purity and its antiserum.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第11期1154-1157,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81172016)
关键词 CA125 原核表达 抗血清制备 CA125 prokaryotic expression antiserumpreparation
  • 相关文献

参考文献10

  • 1Bast RC. Jr, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma[ J]. J Clin Invest, 1981, 68 (5) : 1331 -1337.
  • 2Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene[ J]. Int J Cancer, 2002, 98 (5) : 737 - 740.
  • 3Scholler N, Urban N. CA125 in ovarian cancer[J]. Biomark Med, 2007, 1(4) : 513 -523.
  • 4O'Brien TJ, Beard JB, Underwood LJ, et al. The CA125 gene: an exla'aceUular superstructure dominated by repeat sequences[J]. Tumor Biol, 2001, 22(6) : 348 -366.
  • 5Yin BW, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16 [J]. J Biol Chem, 2001, 276 (29) : 27371 -27375.
  • 6伊正君,付玉荣,许福亮,高昆山,李猛,李建花.结核分枝杆菌调节蛋白RelA的原核表达及多克隆抗体制备[J].细胞与分子免疫学杂志,2012,28(2):170-173. 被引量:12
  • 7谭伟峰,王兰兰,李琦,罗阳,那达翔,马壮,王露.人类新基因CTRP4的原核表达及多克隆抗体的制备[J].细胞与分子免疫学杂志,2012,28(6):614-617. 被引量:6
  • 8Randall LM, Sill MW, Burger RA, et al. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a gynecologic oncology group phase II trial[J]. Gynecol Oncol, 2012, 124(3) : 563 - 568.
  • 9] Patankar MS, Jing Y, Morrison JC, et al. Potent suppression of natu- ral killer cell response mediated by the ovarian tumor marker CA125 [J], Gynecol Oncol, 2005, 99(3) : 704 -713.
  • 10Belisle JA, Gubbels JA, Raphael CA, et al. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125) [J]. Immunology, 2007, 122(3) : 418 -429.

二级参考文献16

  • 1李娜,朱道银,帖儒修,王瑜伟.小鼠Ipr1基因与EGFP基因融合表达载体的构建及其在鼠巨噬细胞中的表达[J].细胞与分子免疫学杂志,2008,24(3):231-233. 被引量:5
  • 2Sajish M,Kalayil S,Verma SK,et al.The significance of EXDD andRXKD motif conservation in Rel proteins[J].J Biol Chem,2009,284(14):9115-9123.
  • 3Primm TP,Andersen SJ,Mizrahi V,et al.The stringent response ofMycobacterium tuberculosis is required for long-term survival[J].JBacteriol,2000,182(17):4889-4898.
  • 4Kishore U, Gaboriaud C, Waters P, et al. Clq and tumor necrosis factur superfamily : modularity and versatility [ J ]. Trends Immunol, 2(104, 25(10) : 551 -561.
  • 5SchMfler A, Buechler C. CTRP family: linking immunity to metabo- lism[ J]. Trends Endocrinol Metab, 2012.
  • 6I Schaffler A, Schohnerich J, Salzberger B. Adipose tissue as an immu- nological organ: Toll-like receptors, Clq/TNFs and CTRPs [ J]. Trends hnmunol, 2007, 28 (9) : 393 - 399.
  • 7Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Molecular, biochemical and functional characterizations of C1 q/TNF family mem-bers : adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinato- rial associations and metabolic functions [ J]. Biochem J, 2008, 416 (2) : 161 - 177.
  • 8Li Q, Wang L, Tan W, et al. Identification of ClqTNF-related pro- tein 4 as a potential cytokine that stimulates the STAT3 and NF-kap- paB pathways and promotes cell survival in human cancer cells [ J ]. Cancer Lett, 2011, 308(2) : 203 -214.
  • 9Robert J Stewait, et al. Rapid Detection of Lactic Acid Bacteria in Fermenter Samples Using a Nested Polymerase Chain Reaction[J].Brew. Chem. 1996,(2): 78-84.
  • 10Jacqueline L, et al. Simpson[J]. Journal of Bacteriology. 1994, 635-638.

共引文献16

同被引文献10

  • 1Li‐Dong Wang,Xiuli Bi,Xin Song,Nicole M. Pohl,Yulan Cheng,Yixing Zhou,Stephen Shears,Emmanuel Ansong,Mengtao Xing,Shaomeng Wang,Xiao‐Chun Xu,Peng Huang,Liyan Xu,Liang Wang,Zongmin Fan,Xueke Zhao,Huali Dong,Stephen J. Meltzer,Ivan Ding,Wancai Yang.A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis[J].Mol Carcinog.2013(S1)
  • 2Chunhua Song,Chang-Deng Hu,Misa Masago,Ken-ichi Kariya,Yuriko Yamawaki-Kataoka,Mitsushige Shibatohge,Dongmei Wu,Takaya Satoh,Tohru Katao.Regulation of a Novel Human Phospholipase C, PLC, through Membrane Targeting by Ras[].Journal of Biological Chemistry.2001
  • 3Grant G. Kelley,Sarah E. Reks,Joanne M. Ondrako,Alan V. Smrcka.Phospholipase Cε: a novel Ras effector[].EMBO Journal.2001
  • 4Isabel Lopez,Eric C. Mak,Jirong Ding,Heidi E. Hamm,Jon W. Lomasn.A Novel Bifunctional Phospholipase C That Is Regulated by G12 and Stimulates the Ras/Mitogen-activated Protein Kinase Pathway[].Journal of Biological Chemistry.2001
  • 5Jussi Koivunen,Vesa Aaltonen,Sanna Koskela,Petri Lehenkari,Matti Laato,Juha Pelton.Protein Kinase C /? Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells[].Cancer Research.2004
  • 6Li Mingzhen,Edamatsu Hironori,Kitazawa Riko,Kitazawa Sohei,Kataoka Tohru.Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis[].Carcinogenesis.2009
  • 7Lilly Y. W. Bourguignon,Eli Gilad,Amy Brightman,Falko Diedrich,Patrick Singlet.Hyaluronan-CD44 Interaction with Leukemia-associated RhoGEF and Epidermal Growth Factor Receptor Promotes Rho/Ras Co-activation, Phospholipase C-Ca2+ Signaling, and Cytoskeleton Modification in Head and Neck Squamous Cell Carcinoma Cells[].Journal of Biological Chemistry.2006
  • 8Yan LingLuo ChunliWu Xiaoh.Involvement of the PLC epsilon/PKC alpha pathway in human BIU-87 bladder cancer cell proliferation[].Cell Biology International.2011
  • 9Oka M,Edamatsu H,Kunisada M,et al.Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cε-knockout mice is associated with decreased cell death[].Carcinogenesis.2012
  • 10郭永灿,罗春丽,蔡晓钟,吴小候,蒲军.磷脂酶Cε基因在膀胱移行细胞癌中表达及其临床意义[J].临床检验杂志,2008,26(1):52-54. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部